Increased alpha-9 human papillomavirus species viral load in human immunodeficiency virus positive women

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Mbulawa, Zizipho Z A ^a,c   Johnson, Leigh F ^a   Marais, Dianne J ^a   Gustavsson, Inger ^b   Moodley, Jennifer R ^a   Coetzee, David ^a   Gyllensten, Ulf ^b   Williamson, Anna Lise ^a,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Human immunodeficiency virus; Human papillomavirus; Viral load

Indexed keywords

ADULT; ALPHAPAPILLOMAVIRUS; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 7; HUMAN PAPILLOMAVIRUS TYPE 9; MAJOR CLINICAL STUDY; MIXED INFECTION; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; COINFECTION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; VIRAL LOAD;

EID: 84893203164     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-51     Document Type: Article

References (26)

1. Castellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 2006, 98:303-315. 10.1093/jnci/djj067, 16507827.
2. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999, 91:226-236. 10.1093/jnci/91.3.226, 10037100.
3. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. HPV in the etiology of human cancer. Vaccine 2006, 24:1-10. 10.1016/j.vaccine.2005.07.047, 16122853.
4. Palefsky J. HPV infection and HPV-associated neoplasia in immunocompromised women. Int J Gynecol Obstet 2006, 94:S56-S64.
5. Lomalisa P, Smith T, Guidozzi F. Human immunodeficiency virus infection and invasive cervical cancer in South Africa. Gynecol Oncol 2000, 77:460-463. 10.1006/gyno.2000.5775, 10831360.
6. Levi JE, Kleter B, Quint WGV, Fink MCS, Canto CLM, Matsubara R, et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002, 40:3341-3345. 10.1128/JCM.40.9.3341-3345.2002, 130803, 12202576.
7. Fontaine J, Hankins C, Money D, Rachlis A, Pourreaux K, Ferenczy A, et al. Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV. J Clin Virol 2008, 43:307-312. 10.1016/j.jcv.2008.07.013, 18786854.
8. Delmas MC, Larsen C, van Benthem B, Hamers FF, Bergeron C, Poveda JD, et al. Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. Aids 2000, 14:1775-1784. 10.1097/00002030-200008180-00013, 10985315.
9. Harris TG, Burk RD, Palefsky JM, Massad LS, Bang JY, Anastos K, et al. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA-J Am Med Assoc 2005, 293:1471-1476.
10. Ho CM, Cheng WF, Chu TY, Chen CA, Chuang MH, Chang SF, et al. Human papillomaviral load changes in low-grade squamous intraepithelial lesions of the uterine cervix. Br J Cancer 2006, 95:1384-1389. 10.1038/sj.bjc.6603430, 2360605, 17060938.
11. Peitsaro P, Johansson B, Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002, 40:886-891. 10.1128/JCM.40.3.886-891.2002, 120275, 11880410.
12. Schulz KF, Grimes DA. Sample size calculations in randomised trials: mandatory and mystical. Lancet 2005, 365:1348-1353. 10.1016/S0140-6736(05)61034-3, 15823387.
13. Mbulawa ZZA, Coetzee D, Marais DJ, Kamupira M, Zwane E, Allan B, et al. Genital human Papillomavirus prevalence and human Papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J Infect Dis 2009, 199:1514-1524. 10.1086/598220, 19392625.
14. Gustavsson I, Juko-Pecirep I, Backlund I, Wilander E, Gyllensten U. Comparison between the Hybrid Capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia. J Clin Virol 2009, 45:85-89. 10.1016/j.jcv.2009.04.012, 19451022.
15. Levi G, Feldman J, Holman S, Salarieh A, Strickler HD, Alter S, et al. Relationship between HIV viral load and Langerhans cells of the cervical epithelium. J Obstet Gynaecol Res 2005, 31:178-184. 10.1111/j.1341-8076.2005.00267.x, 15771646.
16. Swan DC, Tucker RA, Tortolero-Luna G, Mitchell MF, Wideroff L, Unger ER, et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 1999, 37:1030-1034. 88645, 10074522.
17. Luchters SM, Vanden Brorck D, Chersich MF, Nel A, Delva W, Mandaliya K, et al. Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers. BMC Infec Dis Ref Type: Generic 2010, 10:18.
18. Theiler RN, Farr SL, Karon JM, Paramsothy P, Viscidi R, Duerr A, et al. High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women risk factors for cervical viral shedding. Obstet Gynecol 2010, 115:1150-1158. 10.1097/AOG.0b013e3181e00927, 20502284.
19. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005, 97:577-586. 10.1093/jnci/dji073, 15840880.
20. Viscidi RP, Snyder B, Cu-Uvin S, Hogan JW, Clayman B, Klein RS, et al. Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women. Cancer Epidemiol Biomarkers Prev 2005, 14:283-288.
21. Denny L, Boa R, Willimson AL, Allan B, Hardie D, Stan R, et al. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. Obstet Gynecol 2008, 111:1380-1387. 10.1097/AOG.0b013e3181743327, 18515522.
22. Moberg M, Gustavsson I, Wilander E, Gyllensten U. High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer 2005, 92:891-894. 10.1038/sj.bjc.6602436, 2361906, 15756259.
23. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC. Human papillomavirus infection in women infected with the human immunodeficiency virus. New Engl J Med 1997, 337:1343-1349. 10.1056/NEJM199711063371903, 9358128.
24. Gravitt PE, Kovacic MB, Herrero R, Schiffman M, Bratti C, Hildesheim A, et al. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer 2007, 121:2787-2793. 10.1002/ijc.23012, 17722112.
25. Ho GYF, Studentsov YY, Bierman R, Burk RD. Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol Biomarkers Prev 2004, 13:110-116. 10.1158/1055-9965.EPI-03-0191, 14744741.
26. Andersson S, Safari H, Mints M, Lewensohn-Fuchs I, Gyllensten U, Johansson B. Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br J Cancer 2005, 92:2195-2200. 10.1038/sj.bjc.6602648, 2361820, 15942630.